Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CTSO vs $IRIX | Chartloom

Compare

$CTSO vs $IRIX

Cytosorbents Corp · IRIDEX Corp

CTSO

Cytosorbents Corp

IRIX

IRIDEX Corp

Compare $CTSO vs $IRIX

Comparing Cytosorbents Corp and IRIDEX Corp

CTSOCytosorbents Corp

IRIXIRIDEX Corp

CTSOCytosorbents Corp

Market cap

$217M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.02x

Rev growth (TTM)

8.6%

YTD performance

-73.6%

52W performance

-81.1%

FCF yield

-4.5%

IRIXIRIDEX Corp

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

3.7%

YTD performance

-27.5%

52W performance

-18.4%

FCF yield

-13.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTSO

IRIX

Detailed metrics comparison

CTSO

Cytosorbents Corp

IRIX

IRIDEX Corp

Market Cap

CTSO$217M

IRIX$15M

Enterprise Value

CTSO$230M

IRIX$14M

Price

CTSO$3.46

IRIX$0.85

P/E Ratio

CTSON/A

IRIXN/A

P/S Ratio

CTSO5.84x

IRIX0.29x

EV/Sales

CTSO6.19x

IRIX0.27x

EV/EBITDA

CTSO0.00x

IRIX15.52x

P/B Ratio

CTSO5.44x

IRIX4.30x

P/FCF Ratio

CTSON/A

IRIXN/A

EV/FCF

CTSO-23.75x

IRIX-6.94x

PEG Ratio

CTSON/A

IRIXN/A

Forward P/E (NTM)

CTSON/A

IRIXN/A

Forward P/S (NTM)

CTSO5.02x

IRIXN/A

Revenue (TTM)

CTSO$37M

IRIX$52M

Revenue Growth (YoY)

CTSO8.6%

IRIX3.7%

Forward Rev Growth

CTSO13.6%

IRIX6.6%

Gross Margin (TTM)

CTSO71.6%

IRIX35.9%

Operating Margin (TTM)

CTSO0.0%

IRIX0.0%

EBITDA Margin (TTM)

CTSO-28.3%

IRIX-4.5%

Net Margin (TTM)

CTSO-48.9%

IRIX-6.9%

FCF Margin (TTM)

CTSO-26.0%

IRIX-3.9%

Net Income (TTM)

CTSO$-18M

IRIX$-4M

FCF (TTM)

CTSO$-10M

IRIX$-2M

EPS (TTM)

CTSO-$0.29

IRIX-$0.20

ROE (TTM)

CTSO-16513.0%

IRIX-7894.0%

ROA (TTM)

CTSO-4325.0%

IRIX-1255.0%

ROIC (TTM)

CTSO-5193.0%

IRIX-4303.0%

Cash

CTSO$4M

IRIX$5M

Debt

CTSO$17M

IRIX$4M

Net Cash/Debt

CTSO$-13M

IRIX$885K

Current Ratio (TTM)

CTSO0.66x

IRIX1.82x

Quick Ratio (TTM)

CTSO0.47x

IRIX0.89x

Debt/Equity (TTM)

CTSO7.73x

IRIX1.04x

Debt/Assets (TTM)

CTSO0.0%

IRIX0.0%

Interest Coverage (TTM)

CTSON/A

IRIXN/A

Net Debt/EBITDA (TTM)

CTSO0.00x

IRIX0.00x

Beta

CTSO1.51

IRIX0.69

52W Performance

CTSO-81.1%

IRIX-18.4%

YTD Performance

CTSO-73.6%

IRIX-27.5%

% from 52W High

CTSO-82.5%

IRIX-48.5%

% from 52W Low

CTSO1.1%

IRIX39.8%

Asset Turnover (TTM)

CTSO0.88x

IRIX1.83x

FCF Yield (TTM)

CTSO-4.5%

IRIX-13.5%

Earnings Yield (TTM)

CTSO-8.4%

IRIX-24.0%

Dividend Yield (TTM)

CTSON/A

IRIXN/A

Rule of 40

CTSO-17.4

IRIX-0.2

EV/GP/RG

CTSO0.53

IRIX0.11

Ticker research

View CTSO research View IRIX research

Metric	CTSO Cytosorbents Corp	IRIX IRIDEX Corp
Market & Valuation
Market Cap	$217M	$15M
Enterprise Value	$230M	$14M
Price	$3.46	$0.85
P/E Ratio	N/A	N/A
P/S Ratio	5.84x	0.29x
EV/Sales	6.19x	0.27x
EV/EBITDA	0.00x	15.52x
P/B Ratio	5.44x	4.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-23.75x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.02x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$52M
Revenue Growth (YoY)	8.6%	3.7%
Forward Rev Growth	13.6%	6.6%
Profitability
Gross Margin (TTM)	71.6%	35.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-28.3%	-4.5%
Net Margin (TTM)	-48.9%	-6.9%
FCF Margin (TTM)	-26.0%	-3.9%
Net Income (TTM)	$-18M	$-4M
FCF (TTM)	$-10M	$-2M
EPS (TTM)	-$0.29	-$0.20
ROE (TTM)	-16513.0%	-7894.0%
ROA (TTM)	-4325.0%	-1255.0%
ROIC (TTM)	-5193.0%	-4303.0%
Financial Health
Cash	$4M	$5M
Debt	$17M	$4M
Net Cash/Debt	$-13M	$885K
Current Ratio (TTM)	0.66x	1.82x
Quick Ratio (TTM)	0.47x	0.89x
Debt/Equity (TTM)	7.73x	1.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	0.69
52W Performance	-81.1%	-18.4%
YTD Performance	-73.6%	-27.5%
% from 52W High	-82.5%	-48.5%
% from 52W Low	1.1%	39.8%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	1.83x
FCF Yield (TTM)	-4.5%	-13.5%
Earnings Yield (TTM)	-8.4%	-24.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-17.4	-0.2
EV/GP/RG	0.53	0.11
Ticker research	View CTSO research	View IRIX research

Valuation

P/S Ratio

IRIX

0.29x

CTSO

5.84x

EV/FCF

CTSO

-23.75x

IRIX

-6.94x

Growth & revenue

Revenue Growth TTM

CTSO

8.6%

IRIX

3.7%

Forward Revenue Growth

CTSO

13.6%

IRIX

6.6%

Profitability & performance

Gross Margin

CTSO

71.6%

IRIX

35.9%

ROE

IRIX

-7894.0%

CTSO

-16513.0%

FCF Yield %

CTSO

-4.5%

IRIX

-13.5%

52-Week Performance

IRIX

-18.4%

CTSO

-81.1%

Detailed metrics comparison

CTSO

Cytosorbents Corp

IRIX

IRIDEX Corp

Market Cap

CTSO$217M

IRIX$15M

Enterprise Value

CTSO$230M

IRIX$14M

Price

CTSO$3.46

IRIX$0.85

P/E Ratio

CTSON/A

IRIXN/A

P/S Ratio

CTSO5.84x

IRIX0.29x

EV/Sales

CTSO6.19x

IRIX0.27x

EV/EBITDA

CTSO0.00x

IRIX15.52x

P/B Ratio

CTSO5.44x

IRIX4.30x

P/FCF Ratio

CTSON/A

IRIXN/A

EV/FCF

CTSO-23.75x

IRIX-6.94x

PEG Ratio

CTSON/A

IRIXN/A

Forward P/E (NTM)

CTSON/A

IRIXN/A

Forward P/S (NTM)

CTSO5.02x

IRIXN/A

Revenue (TTM)

CTSO$37M

IRIX$52M

Revenue Growth (YoY)

CTSO8.6%

IRIX3.7%

Forward Rev Growth

CTSO13.6%

IRIX6.6%

Gross Margin (TTM)

CTSO71.6%

IRIX35.9%

Operating Margin (TTM)

CTSO0.0%

IRIX0.0%

EBITDA Margin (TTM)

CTSO-28.3%

IRIX-4.5%

Net Margin (TTM)

CTSO-48.9%

IRIX-6.9%

FCF Margin (TTM)

CTSO-26.0%

IRIX-3.9%

Net Income (TTM)

CTSO$-18M

IRIX$-4M

FCF (TTM)

CTSO$-10M

IRIX$-2M

EPS (TTM)

CTSO-$0.29

IRIX-$0.20

ROE (TTM)

CTSO-16513.0%

IRIX-7894.0%

ROA (TTM)

CTSO-4325.0%

IRIX-1255.0%

ROIC (TTM)

CTSO-5193.0%

IRIX-4303.0%

Cash

CTSO$4M

IRIX$5M

Debt

CTSO$17M

IRIX$4M

Net Cash/Debt

CTSO$-13M

IRIX$885K

Current Ratio (TTM)

CTSO0.66x

IRIX1.82x

Quick Ratio (TTM)

CTSO0.47x

IRIX0.89x

Debt/Equity (TTM)

CTSO7.73x

IRIX1.04x

Debt/Assets (TTM)

CTSO0.0%

IRIX0.0%

Interest Coverage (TTM)

CTSON/A

IRIXN/A

Net Debt/EBITDA (TTM)

CTSO0.00x

IRIX0.00x

Beta

CTSO1.51

IRIX0.69

52W Performance

CTSO-81.1%

IRIX-18.4%

YTD Performance

CTSO-73.6%

IRIX-27.5%

% from 52W High

CTSO-82.5%

IRIX-48.5%

% from 52W Low

CTSO1.1%

IRIX39.8%

Asset Turnover (TTM)

CTSO0.88x

IRIX1.83x

FCF Yield (TTM)

CTSO-4.5%

IRIX-13.5%

Earnings Yield (TTM)

CTSO-8.4%

IRIX-24.0%

Dividend Yield (TTM)

CTSON/A

IRIXN/A

Rule of 40

CTSO-17.4

IRIX-0.2

EV/GP/RG

CTSO0.53

IRIX0.11

Ticker research

View CTSO research View IRIX research

Metric	CTSO Cytosorbents Corp	IRIX IRIDEX Corp
Market & Valuation
Market Cap	$217M	$15M
Enterprise Value	$230M	$14M
Price	$3.46	$0.85
P/E Ratio	N/A	N/A
P/S Ratio	5.84x	0.29x
EV/Sales	6.19x	0.27x
EV/EBITDA	0.00x	15.52x
P/B Ratio	5.44x	4.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-23.75x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.02x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$52M
Revenue Growth (YoY)	8.6%	3.7%
Forward Rev Growth	13.6%	6.6%
Profitability
Gross Margin (TTM)	71.6%	35.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-28.3%	-4.5%
Net Margin (TTM)	-48.9%	-6.9%
FCF Margin (TTM)	-26.0%	-3.9%
Net Income (TTM)	$-18M	$-4M
FCF (TTM)	$-10M	$-2M
EPS (TTM)	-$0.29	-$0.20
ROE (TTM)	-16513.0%	-7894.0%
ROA (TTM)	-4325.0%	-1255.0%
ROIC (TTM)	-5193.0%	-4303.0%
Financial Health
Cash	$4M	$5M
Debt	$17M	$4M
Net Cash/Debt	$-13M	$885K
Current Ratio (TTM)	0.66x	1.82x
Quick Ratio (TTM)	0.47x	0.89x
Debt/Equity (TTM)	7.73x	1.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	0.69
52W Performance	-81.1%	-18.4%
YTD Performance	-73.6%	-27.5%
% from 52W High	-82.5%	-48.5%
% from 52W Low	1.1%	39.8%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	1.83x
FCF Yield (TTM)	-4.5%	-13.5%
Earnings Yield (TTM)	-8.4%	-24.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-17.4	-0.2
EV/GP/RG	0.53	0.11
Ticker research	View CTSO research	View IRIX research